Overweight in midlife and risk of dementia: a 40-year follow-up study
Open accessAbstract
Objective:This study examines whether overweight in midlife increases dementia risk later in life.Methods:In 1963 body mass index was assessed in 1152 participants of The Swedish Twin Registry, at the age of 45–65 years. These participants were later screened for dementia in a prospective study with up to 40 years follow-up. A total of 312 participants were diagnosed with dementia.Results:Logistic regression analyses adjusted for demographic factors, smoking and alcohol habits, indicated that men and women categorized as overweight in their midlife had an elevated risk of dementia (OR=1.59; 95% CI: 1.21–2.07, P=0.002), Alzheimer's disease (OR=1.71; 95% CI: 1.24–2.35, P=0.003), and vascular dementia (OR=1.55; 95% CI: 0.98–2.47, P=0.059). Further adjustments for diabetes and vascular diseases did not substantially affect the associations, except for vascular dementia (OR=1.36; 95% CI: 0.82–2.56, P=0.116), reflecting the significance of diabetes and vascular diseases in the etiology of vascular dementia. There was no significant interaction between overweight and APOE ɛ4 status, indicating that having both risk factors does not have a multiplicative effect with regard to dementia risk.Conclusions:This study gives further support to the notion that overweight in midlife increases later risk of dementia. The risk is increased for both Alzheimer's disease and vascular dementia, and follows the same pattern for men and women.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 25 cited sources checked · 0 supported · 0 flagged
- Findingown data
Additional adjustment for diabetes and vascular diseases reduced the association between midlife overweight and vascular dementia to non-significance (OR 1.36, 95% CI 0.82-2.56, p=.116).
“except for vascular dementia (OR = 1.36; 95% CI: 0.82 to 2.56, p = .116)”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“However, the risk was substantially reduced in Model II by including diabetes and vascular diseases (OR = 1.36; p = .162), reflecting the significance of these factors in the aetiology of VaD.”
Quote in the paperSubstantial claim - Also stated in: § Risk of dementia in relation to midlife BMI · plain
- Findingown data
When analysed separately by sex, the link between midlife overweight and dementia risk appeared similar in men and women.
“The sex stratified analyses on BMI and dementia risk showed the same pattern among men and women, therefore, these results will not be presented separately.”
- Also stated in: § Discussion · hedged
“Finally, the sex stratified analyses indicated the same pattern for men and women.”
Quote in the paperNot a substantial claim - Also stated in: § Discussion · hedged
- Findingown data
APOE ε4 carrier status was associated with increased dementia risk (OR 3.99, 95% CI 2.96-5.38, p<.001).
“For APOE ε4 status the OR was 3.99 (95% CI = 2.96 to 5.38, p < .001), confirming the well established role of APOE e4 as a risk factor for dementia.”
Quote in the paperNot a substantial claim - Findingown data
Additional adjustment for diabetes and vascular diseases did not substantially change the association between midlife overweight and all-cause dementia.
“Further adjustments for diabetes and vascular diseases did not substantially affect the associations, except for vascular dementia (OR = 1.36; 95% CI: 0.82 to 2.56, p = .116), reflecting the significance of diabetes and vascular diseases in the aetiology of vascular dementia.”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“Further adjustments for diabetes and vascular diseases in Model II did not substantially change this association.”
Quote in the paperSubstantial claim - Also stated in: § Risk of dementia in relation to midlife BMI · plain
- Findingown data
There was no statistically significant interaction between midlife overweight and APOE ε4 status on dementia risk (p=.781).
“There was no significant interaction between overweight and APOE ε4 status, indicating that having both risk factors does not have a multiplicative effect concerning dementia risk.”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“The interaction between BMI and APOE ε4 was not statistically significant (p = .781), indicating that having both risk factors does not have a multiplicative effect on dementia risk but rather an additive effect (see Table 4).”
Quote in the paperSubstantial claim - Also stated in: § Risk of dementia in relation to midlife BMI · plain
- Findingown data
In the subsample of 732 individuals with APOE ε4 data, midlife overweight was associated with increased dementia risk (OR 1.62, 95% CI 1.17-2.24, p=.008).
“This analysis resulted in an OR of 1.62 (95% CI = 1.17 to 2.24, p = .008) for BMI status (as compared to OR of 1.59 for N=1152).”
Quote in the paperNot a substantial claim - Findingown data
Midlife overweight was associated with an increased risk of Alzheimer's disease after adjustment for demographics, smoking, and alcohol (OR 1.71, 95% CI 1.24-2.35, p=.003).
“Alzheimer’s disease (OR = 1.71; 95% CI: 1.24 to 2.35, p = .003)”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“When BMI was examined in relation to AD the same pattern was found as with all dementia, although the association was stronger in terms of risk, OR = 1.71 in Model I, and OR = 1.68, in the fully adjusted model.”
Quote in the paperSubstantial claim - Also stated in: § Risk of dementia in relation to midlife BMI · plain
- Findingown data
When APOE ε4 status was included as a covariate, midlife overweight remained significantly associated with dementia risk (OR 1.57, 95% CI 1.13-2.20, p=.013).
“When APOE ε4 status was included as a covariate, the association between BMI status and dementia was somewhat weaker, although still statistically significant (OR =1.57, 95% CI = 1.13 to 2.20, p = .013).”
Quote in the paperSubstantial claim - Findingown data
Additional adjustment for diabetes and vascular diseases did not substantially change the association between midlife overweight and Alzheimer's disease.
“When BMI was examined in relation to AD the same pattern was found as with all dementia, although the association was stronger in terms of risk, OR = 1.71 in Model I, and OR = 1.68, in the fully adjusted model.”
Quote in the paperSubstantial claim - Findingown data
Less than 5% of the sample were obese according to the standard BMI criterion (BMI >30).
“In our sample, however, less than 5% were obese according to this criterion.”
Quote in the paperSubstantial claim - Interpretationown data
The link between midlife overweight and dementia risk is similar in men and women.
“and follows the same pattern for men and women”
- Also stated in: § Discussion · hedged
“Finally, the sex stratified analyses indicated the same pattern for men and women.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · hedged
- Interpretationown data
Midlife overweight increases the risk of dementia in later life.
“This study gives further support to the notion that overweight in midlife increases later risk of dementia.”
- Also stated in: § Discussion · plain
“Our results showed that midlife overweight significantly increased the risk of dementia in old age, even after controlling for known comorbid factors related to vascular risk.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Premisecitation
Because aging replaces lean mass with fat, BMI reflects adiposity better in younger than in older people.
“Another reason is that BMI is a better measure of adiposity in younger samples as lean body mass is replaced by fat with increasing age 11.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Baumgartner RN, Heymsfield SB, Roche AF . Human body composition and the epidemiology of chronic disease. Obes Res 1995; 3: 73–95. source
Not checked in the free run.
- Interpretationown data
Midlife overweight remains a significant dementia risk factor after accounting for known vascular comorbidities.
“Our study, along with other studies show that even after controlling for these comorbid risk factors, overweight is still a significant risk factor of dementia.”
Quote in the paperSubstantial claim - Study design and conductown data
Participants were followed prospectively for as long as 40 years.
“These participants were later screened for dementia in a prospective study with up to 40 years follow-up.”
Quote in the paperSubstantial claim - Premisereasoning
Midlife measurement of overweight may better capture a person's long-term exposure to excess weight.
“Finally, and most importantly, measuring overweight in midlife may reflect a more valid perspective on a persons’ lifelong exposure to overweight, especially given the fact that most people tend to gain rather than lose weight in adulthood.”
Quote in the paperSubstantial claim - Interpretationreasoning
The findings apply only to individuals who live long enough to reach the inclusion ages of the aging studies (69+ for SATSA, 80+ for OCTO-Twin).
“This implies that the participants were at the age of 69+ (for the SATSA) and 80+ (for the OCTO-Twin) at inclusion, meaning that the results can only be generalized to people who survive into that age.”
Quote in the paperSubstantial claim - Premisecitation
The point in the life course at which a dementia risk factor is measured affects whether and how its association is observed.
“Thus, when in the life course a risk factor for dementia is measured determines if and how the association is characterized 12, 13.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Weight loss commonly occurs before dementia diagnosis and early in the disease, which can obscure the overweight-dementia association in older samples.
“Overweight should be measured in midlife in order to reveal the association to subsequent dementia because people often lose weight prior to diagnosis 9 and early in the dementia phase 10.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2005; 62: 55–60. source
Not checked in the free run.
- cites [10] White H, Pieper C, Schmader K . The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc 1998; 46: 1223–1227. source
Not checked in the free run.
- Interpretationcitation
The present findings agree with those of other studies that assessed overweight in midlife and used long follow-up for dementia.
“Generally, our results are in congruence with results from studies where overweight is measured in midlife and the follow up time for the dementia outcome is extensive 2–4.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [2] Rosengren A, Skoog I, Gustafson D, Wilhelmsen L . Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005; 165: 321–326. source
Not checked in the free run.
- cites [3] Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry Jr CP, Yaffe K . Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360. source
Not checked in the free run.
- cites [4] Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K . Central obesity and increased risk of dementia more than three decades later. Neurology 2008; 71: 1057–1064. source
Not checked in the free run.
- May combine two claims. 14
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 12
May combine two claims.
Findingown dataMidlife overweight was associated with an increased risk of vascular dementia after adjustment for demographics, smoking, and alcohol, but the association was not statistically significant (OR 1.55, 95% CI 0.98-2.47, p=.059).
“vascular dementia (OR = 1.55; 95% CI: 0.98 to 2.47, p = .059)”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“Concerning VaD, the risk associated with higher BMI fell short out of significance in Model I, (OR = 1.55; p = .059).”
Quote in the paperNot a substantial claim- Also stated in: § Risk of dementia in relation to midlife BMI · plain
The quote only partly states this claim.
Findingown dataIn the study sample of 1152 Swedish twins aged 45-65 in 1963, midlife overweight (BMI ≥26.5, top 25%) was associated with an increased risk of all-cause dementia in later life after adjustment for demographics, smoking, and alcohol (OR 1.59, 95% CI 1.21-2.07, p=.002).
“Logistic regression analyses, adjusted for demographic factors, smoking and alcohol habits, indicated that men and women categorized as overweight in their midlife had an elevated risk of dementia (OR = 1.59; 95% CI: 1.21 to 2.07, p = .002)”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“Model I (adjusted for demographics, smoking, and alcohol use) showed that midlife overweight was associated with greater risk of dementia, such that those with a BMI above the third quartile had a 59% greater risk of getting dementia in old age as compared with those with lower BMI.”
Quote in the paperSubstantial claim- Also stated in: § Risk of dementia in relation to midlife BMI · plain
May combine two claims.
Findingown dataIn the fully adjusted model for vascular dementia, congestive heart failure and stroke were significant predictors (ORs 1.98 and 6.97), while diabetes was marginally significant (OR 1.65, p=.067).
“In this model, congestive heart failure (OR = 1.98), and stroke (OR = 6.97) were significantly related to risk of VaD (ps < .05), whereas diabetes was marginally significant (OR = 1.65; p = .067).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCompared with controls, dementia cases were more often women, older, less educated, had shorter survival, more often abstained from alcohol, and had higher rates of congestive heart failure, stroke, APOE ε4 carriage, and BMI (ps < .05).
“There were statistically significant differences between controls and cases, such that the dementia group had more women, were older, had fewer years of education, had shorter survival, comprised more individuals who did not use alcohol, had more prevalent congestive heart failure, stroke, and APOE ε4 carriers, and a higher BMI (ps < .05).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCompared with the normal weight group, the overweight group included more people with hypertension, congestive heart failure, and diabetes (ps < .05).
“There were statistically significant differences between the normal weight group and the overweight group, such that the overweight group had fewer years of education, comprised more individuals who did not use alcohol, hade more individuals with hypertension, congestive heart failure, and diabetes (ps < .05).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataDementia diagnoses in this study came from a detailed clinical assessment, giving high confidence in the outcome classification.
“In our study the dementia diagnoses were made through a thorough clinical procedure, resulting in a highly confident outcome diagnosis.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductcitationSelf-reported height and weight data are valid and reliable, as shown by correlations of 0.97 for height and 0.95 for weight between self-reported and measured values in SATSA.
“However, analyses completed in the SATSA comparing self-reported and measured information on heights and weights (within a one year period) resulted in a correlation of 0.97 for height and 0.95 for weight20.”
- Also stated in: § Discussion · hedged
“However, correlational analyses conducted on SATSA20, comparing self reported and measured data on heights and weights, resulted in correlation of 0.97 for height and 0.95 for weight, supporting a notion of valid and reliable self reported data.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Stunkard AJ, Harris JR, Pedersen NL, McClearn GE . The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483–1487. source
Not checked in the free run.
- Also stated in: § Discussion · hedged
May combine two claims.
Interpretationown dataDiabetes and vascular diseases are important causal factors in vascular dementia.
“reflecting the significance of diabetes and vascular diseases in the aetiology of vascular dementia”
- Also stated in: § Risk of dementia in relation to midlife BMI · plain
“reflecting the significance of these factors in the aetiology of VaD”
Quote in the paperSubstantial claim- Also stated in: § Risk of dementia in relation to midlife BMI · plain
May combine two claims.
Interpretationown dataMidlife overweight raises the risk of both Alzheimer's disease and vascular dementia.
“The risk is increased for both Alzheimer’s disease and vascular dementia, and follows the same pattern for men and women.”
- Also stated in: § Discussion · plain
“Further, the risk was increased for both AD and VaD.”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
May combine two claims.
Interpretationown dataThe combined presence of midlife overweight and APOE ε4 does not multiply dementia risk; their effects add together.
“indicating that having both risk factors does not have a multiplicative effect concerning dementia risk”
- Also stated in: § Risk of dementia in relation to midlife BMI · hedged
“indicating that having both risk factors does not have a multiplicative effect on dementia risk but rather an additive effect (see Table 4)”
Quote in the paperSubstantial claim- Also stated in: § Risk of dementia in relation to midlife BMI · hedged
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWhitmer and colleagues reported that overweight raised AD and VaD risk similarly (about twofold), while obesity was linked more strongly to VaD (fivefold) than to AD (threefold).
“In the study of Whitmer et al.15 overweight (BMI between 25 and 30) increased the risk of AD and VaD to the same extent (approximately a two- fold increased risk), whereas obesity (BMI ≥ 30) was more strongly related to VaD, indicating a five-fold risk, as compared to a three-fold risk of AD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Whitmer RA, Gunderson EP, Quesenberry Jr CP, Zhou J, Yaffe K . Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 2007; 4: 103–109. source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataAdditional models controlled for diabetes and vascular diseases.
“Further adjustments for diabetes and vascular diseases”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationDementia prevalence in SATSA and OCTO-Twin is similar to that reported in the Kungsholmen study in Sweden and the Framingham study in the U.S.
“Prevalence rates of dementia in SATSA and OCTO-Twin have been found to resemble other similar studies such as the Kungsholmen study25 in Sweden, and the Framingham study26 in the U.S.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [25] Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991; 41: 1886–1892. source
Not checked in the free run.
- cites [26] Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992; 42: 115–119. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationAccording to those reviews, significant associations between overweight and dementia came from studies with younger baseline samples and longer follow-up.
“According to the reviews, the studies that reported significant associations had younger samples at baseline and longer follow-up periods.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Beydoun MA, Beydoun HA, Wang Y . Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9: 204–218. source
Not checked in the free run.
- cites [8] Gorospe EC, Dave JK . The risk of dementia with increased body mass index. Age Ageing 2007; 36: 23–29. source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationIn prior work, midlife BMI predicted dementia only in women, while skinfold thickness predicted it in both sexes, suggesting BMI poorly measures adiposity in men.
“By using midlife assessment of BMI and skinfold thickness3, it was found that midlife BMI predicted dementia among women only, whereas midlife skinfold thickness predicted dementia in both sexes, suggesting that BMI is an inaccurate measure of adiposity in men.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry Jr CP, Yaffe K . Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationTwo recent systematic reviews proposed that a high body mass index is independently linked to dementia risk.
“In two recent systematic review articles 7, 8 on overweight and risk of dementia it was proposed that high body mass index (BMI) is independently associated with risk of dementia.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Beydoun MA, Beydoun HA, Wang Y . Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008; 9: 204–218. source
Not checked in the free run.
- cites [8] Gorospe EC, Dave JK . The risk of dementia with increased body mass index. Age Ageing 2007; 36: 23–29. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCarrying the APOE ε4 allele is an established risk factor for both vascular disease and dementia.
“APOE ε4 carrier status is a known risk factor for vascular disease and dementia 29, 30.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [29] Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923. source
Not checked in the free run.
- cites [30] Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649–9653. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationOverweight may confer a greater dementia risk in women than in men.
“Studies that have addressed potential sex differences in the association between overweight and dementia risk indicate that overweight may be a stronger risk factor for women as compared to men 3, 14.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry Jr CP, Yaffe K . Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360. source
Not checked in the free run.
- cites [14] Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 2006; 20: 93–100. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent study by the same group found that central obesity in midlife predicted dementia.
“In a recent study by the same group, midlife central obesity was found to predict dementia 4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K . Central obesity and increased risk of dementia more than three decades later. Neurology 2008; 71: 1057–1064. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHayden and colleagues observed increased dementia risk only among women, but noted low power in their male analyses.
“Hayden et al.14 who used BMI in a sample of people aged 65 years and older to predict incident dementia, found an increased risk only for women, however, the authors reported a problem with low statistical power in the analyses of men.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 2006; 20: 93–100. source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataAnalyses controlled for demographic variables, smoking, and alcohol use.
“Logistic regression analyses, adjusted for demographic factors, smoking and alcohol habits”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTwo studies found that overweight raised Alzheimer's disease risk but not vascular dementia risk in women.
“Two studies reported that overweight increases the risk of AD and not VaD in women 1, 14.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I . An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524–1528. source
Not checked in the free run.
- cites [14] Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 2006; 20: 93–100. source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataStatistical models that account for the non-independence of twin pairs were used in the analysis.
“This was, however, dealt with in the statistical analyses by using multilevel models that account for the dependency within pairs.”
- Also stated in: § Data analyses · plain
“to account for the hierarchical structure in the data while accounting for the dependency associated with twin pair status”
Quote in the paperSubstantial claim- Also stated in: § Data analyses · plain
The authors state this as an assumption.
The random effect of the intercept across twin pairs is normally distributed with mean zero.
“The random effect was assumed to take a normal distribution with a mean of zero.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Midlife obesity is a risk factor for Alzheimer's disease and vascular dementia.
“extant literature that demonstrates midlife obesity as a risk factor for Alzheimer’s disease and vascular dementia.24–26”
From Cognitive Function After Bariatric Surgery: Evidence for Improvement 3 Years After Surgery (2014) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting p-values for the adjusted vascular dementia result
MinorThe abstract and Results section report different p-values for the same adjusted vascular dementia odds ratio: .116 and .162, respectively.
“except for vascular dementia (OR = 1.36; 95% CI: 0.82 to 2.56, p = .116)”
“the risk was substantially reduced in Model II by including diabetes and vascular diseases (OR = 1.36; p = .162)”
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
Hierarchical Linear Models: Applications and Data Analysis Methods.
Longford, N. T., Bryk, A. S., & Raudenbush, S. W. (1993) · Contemporary Sociology A Journal of Reviews · doi:10.2307/2075823 · Cited by 18,768 · see citing works
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210 · see citing works
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · see citing works
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · see citing works
The Body-Mass Index of Twins Who Have Been Reared Apart
Stunkard, A. J., Harris, J. R., Pedersen, N. L., & McClearn, G. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222102 · Cited by 1,286 · see citing works
Self-citationObesity in middle age and future risk of dementia: a 27 year longitudinal population based study
Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., & Yaffe, K. (2005) · BMJ · doi:10.1136/bmj.38446.466238.e0 · Cited by 1,090 · see citing works
An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease
Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811 · see citing works
Central obesity and increased risk of dementia more than three decades later
Whitmer, R. A., Gustafson, D. R., Barrett-Connor, E., Haan, M. N., Gunderson, E. P., & Yaffe, K. (2008) · Neurology · doi:10.1212/01.wnl.0000306313.89165.ef · Cited by 803 · see citing works
Substantial Genetic Influence on Cognitive Abilities in Twins 80 or More Years Old
McClearn, G. E., Johansson, B. E. A., Berg, S., Pedersen, N. L., Ahern, F. M., Petrill, S. A., & Plomin, R. J. (1997) · Science · doi:10.1126/science.276.5318.1560 · Cited by 727 · see citing works
Self-citationThe Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies
Lichtenstein, P., Fairé, U. D., Floderus, B., Svartengren, M., Svedberg, P., & Pedersen, N. L. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01032.x · Cited by 696 · see citing works
Self-citationBeydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563 · see citing works
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study
Bachman, D. L., Wolf, P. A., Linn, R., Knoefel, J. E., CobbS, J., Belanger, A., D'Agostino, R. B., & White, L. R. (1992) · Neurology · doi:10.1212/wnl.42.1.115 · Cited by 527 · see citing works
Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafström, M., Holmen, K., Ericsson, K., Bäckman, L., Ahlbom, A., & Winblad, B. (1991) · Neurology · doi:10.1212/wnl.41.12.1886 · Cited by 525 · see citing works
Stewart, R., Masaki, K., Xue, Q.-L., Peila, R., Petrovitch, H., White, L. R., & Launer, L. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.55 · Cited by 478 · see citing works
Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Whitmer, R., Gunderson, E., Quesenberry, C., Zhou, J., & Yaffe, K. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362047 · Cited by 430 · see citing works
Human Body Composition and the Epidemiology of Chronic Disease
Baumgartner, R. N., Heymsfield, S. B., & Roche, A. F. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00124.x · Cited by 413 · see citing works
The Swedish Twin Registry in the Third Millennium: An Update
Lichtenstein, P., Sullivan, P. F., Cnattingius, S., Gatz, M., Johansson, S., Carlström, E. L., Björk, C., Svartengren, M., Wolk, A., Klareskog, L., et al. (2006) · Twin Research and Human Genetics · doi:10.1375/183242706779462444 · Cited by 399 · see citing works
Self-citationThe Swedish Twin Registry in the Third Millennium: An Update
Lichtenstein, P., Sullivan, P. F., Cnattingius, S., Gatz, M., Johansson, S., Carlström, E. L., Björk, C., Svartengren, M., Wolk, A., Klareskog, L., et al. (2006) · Twin Research and Human Genetics · doi:10.1375/twin.9.6.875 · Cited by 327 · see citing works
Self-citationWhite, H., Pieper, C., & Schmader, K. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04537.x · Cited by 323 · see citing works
The Swedish Adoption Twin Study of Aging: An Update
Pedersen, N. L., McClearn, G. E., Plomin, R. J., Nesselroade, J. R., Berg, S., & DeFaire, U. (1991) · Acta geneticae medicae et gemellologiae · doi:10.1017/s0001566000006681 · Cited by 301 · see citing works
Self-citationVascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study
Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Khachaturian, A. S., Bastian, L. A., Charoonruk, G., Tschanz, J. T., Norton, M. C., Pieper, C. F., Munger, R. G., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213814.43047.86 · Cited by 293 · see citing works
Adiposity indices and dementia
Gustafson, D. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70526-9 · Cited by 237 · see citing works
Body Mass Index, Other Cardiovascular Risk Factors, and Hospitalization for Dementia
Rosengren, A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.321 · Cited by 207 · see citing works
The risk of dementia with increased body mass index
Gorospe, E. C., & Dave, J. K. (2006) · Age and Ageing · doi:10.1093/ageing/afl123 · Cited by 162 · see citing works
The epidemiologic study of dementia: a life-long quest?
Launer, L. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.016 · Cited by 142 · see citing works
Bruun, J. M., Pedersen, S. B., Kristensen, K., & Richelsen, B. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00007-2 · Cited by 141 · see citing works
How heritable is Alzheimer's disease late in life? Findings from Swedish twins
Pedersen, N. L., Gatz, M., Berg, S., & Johansson, B. E. A. (2003) · Annals of Neurology · doi:10.1002/ana.10999 · Cited by 131 · see citing works
Self-citationDahl, A., Hassing, L. B., Fransson, E. I., Berg, S., Gatz, M., Reynolds, C. A., & Pedersen, N. L. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp035 · Cited by 131 · see citing works
Self-citationMetabolic Syndrome and Cognitive Decline
Yaffe, K. S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362191 · Cited by 108 · see citing works
Beydoun, M. A., Lhotsky, A., Wang, Y., Forno, G. D., An, Y., Metter, E. J., Ferrucci, L., O’Brien, R., & Zonderman, A. B. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn229 · Cited by 108 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173 · see citing works
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969 · see citing works
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723 · see citing works
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.017 · Cited by 697 · see citing works
Felice, F. G. D., & Ferreira, S. T. (2014) · Diabetes · doi:10.2337/db13-1954 · Cited by 647 · see citing works
Midlife overweight and obesity increase late-life dementia risk
Xu, W., Atti, A. R., Gatz, M., Pedersen, N. L., Johansson, B. E. A., & Fratiglioni, L. (2011) · Neurology · doi:10.1212/wnl.0b013e3182190d09 · Cited by 479 · see citing works
Self-citationBMI and risk of dementia in two million people over two decades: a retrospective cohort study
Qizilbash, N., Gregson, J., Johnson, M. E., Pearce, N. E., Douglas, I., Wing, K., Evans, S. J. W., & Pocock, S. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00033-9 · Cited by 477 · see citing works
Pedditizi, E., Peters, R. K., & Beckett, N. S. (2016) · Age and Ageing · doi:10.1093/ageing/afv151 · Cited by 476 · see citing works
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441 · see citing works
Energy intake and exercise as determinants of brain health and vulnerability to injury and disease
Mattson, M. P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.012 · Cited by 434 · see citing works
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118333 · Cited by 362 · see citing works
Stroke and dementia risk: A systematic review and meta‐analysis
Kuźma, E., Lourida, I., Moore, S. F., Levine, D. A., Ukoumunne, O. C., & Llewellyn, D. J. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3061 · Cited by 376 · see citing works
Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier
Dyken, P. C. V., & Lacoste, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00930 · Cited by 363 · see citing works
Ratey, J. J., & Loehr, J. E. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.017 · Cited by 308 · see citing works
The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
Forny‐Germano, L., Felice, F. G. D., & Vieira, M. N. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01027 · Cited by 298 · see citing works
2003-2013: A Decade of Body Mass Index, Alzheimer's Disease, and Dementia
Emmerzaal, T. L., Kiliaan, A. J., & Gustafson, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141086 · Cited by 295 · see citing works
Albanese, E., Launer, L. J., Egger, M., Prince, M. J., Giannakopoulos, P., Wolters, F. J., & Egan, K. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.05.007 · Cited by 272 · see citing works
Pedditzi, E., Peters, R. K., & Beckett, N. S. (2016) · Age and Ageing · doi:10.1093/ageing/afw095 · Cited by 279 · see citing works
Role of metabolism in neurodegenerative disorders
Procaccini, C., Santopaolo, M., Faicchia, D., Colamatteo, A., Formisano, L., de Candia, P., Galgani, M., De Rosa, V., & Matarese, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.018 · Cited by 258 · see citing works
Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M., & Lawrence, C. B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.010 · Cited by 232 · see citing works
Cognitive decline, dietary factors and gut–brain interactions
Caracciolo, B., Xu, W., Collins, S. M., & Fratiglioni, L. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.011 · Cited by 205 · see citing works
Cognitive Function and Decline in Obesity
Stanek, K. M., & Gunstad, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111073 · Cited by 178 · see citing works
Cognitive Function After Bariatric Surgery: Evidence for Improvement 3 Years After Surgery
Alosco, M. L., Galioto, R., Spitznagel, M. B., Strain, G., Devlin, M., Cohen, R., Crosby, R. D., Mitchell, J. E., & Gunstad, J. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.05.018 · Cited by 172 · see citing works
Enhanced neural activation with blueberry supplementation in mild cognitive impairment
Boespflug, E. L., Eliassen, J. C., Dudley, J. A., Shidler, M. D., Kalt, W., Summer, S. S., Stein, A. L., Stover, A. N., & Krikorian, R. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1287833 · Cited by 171 · see citing works
Poor cognitive ageing: Vulnerabilities, mechanisms and the impact of nutritional interventions
Miquel, S., Champ, C., Day, J. E. L., Aarts, E., Bahr, B. A., Bakker, M. J., Bánáti, D., Calabrese, V., Cederholm, T., Cryan, J. F., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.004 · Cited by 163 · see citing works
Bouret, S., Levin, B. E., & Ozanne, S. E. (2015) · Physiological Reviews · doi:10.1152/physrev.00007.2014 · Cited by 157 · see citing works
Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia
Hsu, T. M., & Kanoski, S. E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00088 · Cited by 157 · see citing works
Lee, C. M., Woodward, M., Batty, G. D., Beiser, A. S., Bell, S., Berr, C., Bjertness, E., Chalmers, J., Clarke, R., Dartigues, J., et al. (2020) · Obesity Reviews · doi:10.1111/obr.12989 · Cited by 142 · see citing works
Self-citationMeng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150 · see citing works
Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance
Ezkurdia, A., Ramírez, M. J., & Solas, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054354 · Cited by 153 · see citing works
Chuang, Y.-F., An, Y., Bilgel, M., Wong, D. F., Troncoso, J. C., O’Brien, R., Breitner, J. C. S., Ferrucci, L., Resnick, S. M., & Thambisetty, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.129 · Cited by 141 · see citing works
Leptin regulation of hippocampal synaptic function in health and disease
Irving, A. J., & Harvey, J. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0155 · Cited by 123 · see citing works
Leptin Dysfunction and Alzheimer’s Disease: Evidence from Cellular, Animal, and Human Studies
McGuire, M. J., & Ishii, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0282-7 · Cited by 125 · see citing works
Improved memory function two years after bariatric surgery
Alosco, M. L., Spitznagel, M. B., Strain, G. W., Devlin, M. J., Cohen, R. A., Paul, R. H., Crosby, R. D., Mitchell, J. E., & Gunstad, J. (2013) · Obesity · doi:10.1002/oby.20494 · Cited by 123 · see citing works
Meakin, P. J., Harper, A. J., Hamilton, D. L., Gallagher, J. R., McNeilly, A. D., Burgess, L. A., Vaanholt, L. M., Bannon, K. A., Latcham, J., Hussain, I., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110512 · Cited by 119 · see citing works
Obesity-induced Cognitive Impairment in Older Adults: a Microvascular Perspective.
Balasubramanian, P., Kiss, T., Tarantini, S., Nyúl-Tóth, Á., Ahire, C., Yabluchanskiy, A., Csípő, T., Lipécz, Á., Tabák, Á., Institoris, A., et al. (2020) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2020 · Cited by 106 · see citing works
Body mass index and cognitive function: the potential for reverse causation
Suemoto, C. K., Gilsanz, P., Mayeda, E. R., & Glymour, M. M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.83 · Cited by 114 · see citing works
Weight management in older adults
Gill, L. E., Bartels, S. J., & Batsis, J. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0161-z · Cited by 109 · see citing works
The Cognitive Control of Eating and Body Weight: It’s More Than What You “Think”
Davidson, T. L., Jones, S., Roy, M., & Stevenson, R. J. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00062 · Cited by 114 · see citing works
Hassing, L. B., Dahl, A., Pedersen, N. L., & Johansson, B. E. A. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000314874 · Cited by 108 · see citing works
Self-citationQiu, C., Xu, W., & Fratiglioni, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091663 · Cited by 107 · see citing works
Is Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
Marco, L. Y. D., Farkas, E., Martin, C. J., Venneri, A., & Frangi, A. F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142976 · Cited by 93 · see citing works
Li, X.-Y., Zhang, M., Xu, W., Li, J., Cao, X., Yu, J., & Tan, L. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200103111253 · Cited by 90 · see citing works
Bariatric Surgery Patients Exhibit Improved Memory Function 12 Months Postoperatively
Miller, L. A., Crosby, R. D., Galioto, R., Strain, G. W., Devlin, M. J., Wing, R. R., Cohen, R. A., Paul, R. H., Mitchell, J. E., & Gunstad, J. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0970-7 · Cited by 88 · see citing works
Body mass index and neurocognitive functioning across the adult lifespan.
Stanek, K. M., Strain, G. W., Devlin, M. J., Cohen, R., Paul, R. H., Crosby, R. D., Mitchell, J. E., & Gunstad, J. (2013) · Neuropsychology · doi:10.1037/a0031988 · Cited by 82 · see citing works
Neuroprotective effects of leptin in the context of obesity and metabolic disorders
Davis, C., Mudd, J., & Hawkins, M. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.012 · Cited by 83 · see citing works
The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives
Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 83 · see citing works
Change in Body Mass Index Before and After Alzheimer’s Disease Onset
Gu, Y., Scarmeas, N., Cosentino, S., Brandt, J., Albert, M., Blacker, D., Dubois, B., & Stern, Y. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131120110930 · Cited by 75 · see citing works
Bravell, M. E., Westerlind, B., Midlöv, P., Östgren, C. J., Borgqúist, L., Lannering, C., & Mölstad, S. (2010) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2010.06.011 · Cited by 74 · see citing works
Neurocognitive Effects of Obesity and Bariatric Surgery
Spitznagel, M. B., Hawkins, M. A. W., Alosco, M. L., Galioto, R., García, S., Miller, L. A., & Gunstad, J. (2015) · European Eating Disorders Review · doi:10.1002/erv.2393 · Cited by 70 · see citing works
Martins, I. V. A., Rivers‐Auty, J., Allan, S. M., & Lawrence, C. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160640 · Cited by 70 · see citing works
Cardiac Disease Associated With Increased Risk of Nonamnestic Cognitive Impairment
Roberts, R. O., Geda, Y. E., Knopman, D. S., Cha, R. H., Pankratz, V. S., Boeve, B. F., Tangalos, E. G., Ivnik, R. J., Mielke, M. M., & Petersen, R. C. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.607 · Cited by 67 · see citing works
Guan, J., Huang, C.-Q., Li, Y., Wan, C., You, C., Wang, Z., Liu, Y., & Liu, Q. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111160 · Cited by 66 · see citing works
Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
Khan, M. S. H., & Hegde, V. K. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020042 · Cited by 64 · see citing works
Ishii, M., & Iadecola, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.029 · Cited by 64 · see citing works
Yuan, T., Chu, C., Shi, R., Cui, T., Zhang, X., Zhao, Y., Shi, X., Yan, H., Pan, J., Qian, R., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01436 · Cited by 64 · see citing works
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
Bem, A. F. D., Krolow, R., Farias, H. R., de Rezende, V. L., Gelain, D. P., Moreira, J. C. F., Duarte, J. M. N., & de Oliveira, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.604150 · Cited by 64 · see citing works
Atherosclerosis in epilepsy: Its causes and implications
Hamed, S. A. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.07.003 · Cited by 63 · see citing works
Obesity and brain illness: from cognitive and psychological evidences to obesity paradox
Monda, V., Marra, M. L., Perrella, R., Caviglia, G., Iavarone, A., Chieffi, S., Messina, G., Carotenuto, M., Monda, M., & Messina, A. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s148392 · Cited by 63 · see citing works
More than the sum of its parts? Nutrition in Alzheimer's disease
Arnim, C. A. F. V., Gola, U., & Biesalski, H. K. (2010) · Nutrition · doi:10.1016/j.nut.2009.11.009 · Cited by 60 · see citing works
The link between iron, metabolic syndrome, and Alzheimer’s disease
Grünblatt, E., Bartl, J., & Riederer, P. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0426-3 · Cited by 56 · see citing works
Targeting Insulin Resistance to Treat Cognitive Dysfunction
Tyagi, A., & Pugazhenthi, S. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02283-3 · Cited by 55 · see citing works
Diabetes type II: A risk factor for depression-Parkinson–Alzheimer?
Riederer, P., Bartl, J., Laux, G., & Grünblatt, E. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9203-1 · Cited by 51 · see citing works
Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs
Renner, S., Blutke, A., Dobenecker, B., Dhom, G., Müller, T. D., Finan, B., Clemmensen, C., Bernau, M., Novak, I., Rathkolb, B., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.015 · Cited by 50 · see citing works
Rodrigue, C., Ouellette, A.-S., Lemieux, S., Tchernof, A., Biertho, L., & Bégin, C. (2018) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · doi:10.1007/s40519-018-0530-1 · Cited by 45 · see citing works
Meningeal and choroid plexus cells—Novel drug targets for CNS disorders
Dragunow, M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.013 · Cited by 50 · see citing works
Lee, T. H.-Y., Formolo, D. A., Kong, T., Lau, S. W.-Y., Ho, C. S.-L., Leung, R. Y. H., Hung, F. H.-Y., & Yau, S. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.06.002 · Cited by 49 · see citing works
Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia
Cova, I., Clerici, F., Maggiore, L., Pomati, S., Cucumo, V., Ghiretti, R., Galimberti, D., Scarpini, E. A., Mariani, C. B., & Caracciolo, B. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000444216 · Cited by 49 · see citing works
Chronic administration of ellagic acid improved the cognition in middle-aged overweight men
Liu, Y., Yu, S., Wang, F., Yu, H., Li, X., Dong, W.-R., Lin, R., & Liu, Q. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0583 · Cited by 45 · see citing works
Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 44 · see citing works
Diabetes Mellitus Increases Risk of Incident Dementia in APOE ɛ 4 Carriers: A Meta-Analysis
Li, L. Y., Cavuoto, M. G., Biddiscombe, K. J., & Pike, K. E. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191068 · Cited by 45 · see citing works
Overweight and Obesity in Midlife and Brain Structure and Dementia 26 Years Later
Albanese, E., Davis, B. J. K., Jónsson, P. V., Chang, M., Aspelund, T., García, M., Harris, T. B., Gudnason, V. G., & Launer, L. J. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu331 · Cited by 43 · see citing works
Food for thought: Leptin regulation of hippocampal function and its role in Alzheimer's disease
McGregor, G., & Harvey, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.038 · Cited by 42 · see citing works
Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
Pražienková, V., Popelová, A., Kuneš, J., & Maletı́nská, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215297 · Cited by 42 · see citing works
Mitochondrial Dysfunctions: A Thread Sewing Together Alzheimer’s Disease, Diabetes, and Obesity
Rigotto, G., & Basso, E. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7210892 · Cited by 43 · see citing works
Impact of obesity and diet on brain structure and function: a gut–brain–body crosstalk
Medawar, E., & Witte, A. V. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122002786 · Cited by 40 · see citing works
Abdominal obesity and white matter microstructure in midlife
Birdsill, A. C., Oleson, S., Kaur, S., Pasha, E. P., Ireton, A., Tanaka, H., & Haley, A. P. (2017) · Human Brain Mapping · doi:10.1002/hbm.23576 · Cited by 37 · see citing works
Brain aging: lessons from community studies
Fratiglioni, L., Mangialasche, F., & Qiu, C. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00353.x · Cited by 39 · see citing works
Effect of a Vegan Diet on Alzheimer’s Disease
Katonová, A., Sheardová, K., Amlerová, J., Angelucci, F., & Hort, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314924 · Cited by 39 · see citing works
Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease
Bayraktaroğlu, I., Ortí-Casañ, N., Dam, D. V., Deyn, P. P. D., & Eisel, U. L. M. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00529-5 · Cited by 42 · see citing works
The Neuronal Actions of Leptin and the Implications for Treating Alzheimer’s Disease
Hamilton, K., & Harvey, J. (2021) · Pharmaceuticals · doi:10.3390/ph14010052 · Cited by 36 · see citing works
Associations of BMI and Serum Urate with Developing Dementia: A Prospective Cohort Study
Cao, Z., Xu, C., Yang, H., Li, S., Xu, F., Zhang, Y., & Wang, Y. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa638 · Cited by 37 · see citing works
Perdoncin, M., Konrad, A., Wyner, J. R., Lohana, S., Pillai, S. S., Pereira, D. G., Lakhani, H. V., & Sodhi, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.756499 · Cited by 38 · see citing works
Dementia in Swedish Twins: Predicting Incident Cases
Gatz, M., Reynolds, C. A., Finkel, D., Pedersen, N. L., & Walters, E. E. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9407-4 · Cited by 34 · see citing works
Self-citationBlood pressure and Alzheimer's disease: A review of meta-analysis
Saiz-Vázquez, O., Puente-Martínez, A., Pacheco, J., & Ubillos-Landa, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1065335 · Cited by 30 · see citing works
Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 30 · see citing works
Body mass index (BMI) at an early age and the risk of dementia
Chen, Y., Chen, T., Yip, P., Hu, C.-Y., Chu, Y., & Chen, J. (2010) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(10)70013-3 · Cited by 31 · see citing works
Olivo, G., Gour, S., & Schiöth, H. B. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.014 · Cited by 29 · see citing works
Wang, H., Wu, M., Diao, J.-L., Li, J., Sun, Y., & Xiao, X. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0257-1 · Cited by 28 · see citing works
Rao, L. S. N., Kilari, E. K., & Kola, P. K. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1616436 · Cited by 27 · see citing works
Hazar, N., Seddigh, L., Rampisheh, Z., & Nojomi, M. (2016) · Europe PMC (PubMed Central) · Cited by 26 · see citing works
Effects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet
Lin, D.-T., Kao, N.-J., Cross, T.-W., Lee, W., & Lin, S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108974 · Cited by 25 · see citing works
Brinkley, T. E., Leng, I., Register, T. C., Neth, B. J., Zetterberg, H., Blennow, K., & Craft, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.906539 · Cited by 24 · see citing works
Wei, J., Zhu, X., Liu, J., Gao, Y., Liu, X., Wang, K., & Zheng, X. (2024) · Obesity Reviews · doi:10.1111/obr.13882 · Cited by 23 · see citing works
Pre-operative history of depression and cognitive changes in bariatric surgery patients
Alosco, M. L., Spitznagel, M. B., Strain, G. W., Devlin, M. J., Cohen, R. A., Crosby, R. D., Mitchell, J. E., & Gunstad, J. (2014) · Psychology Health & Medicine · doi:10.1080/13548506.2014.959531 · Cited by 23 · see citing works
Dahl, A. (2009) · University Library of Skövde (University of Skövde) · Cited by 23 · see citing works
Self-citationDiabesity and Brain Energy Metabolism: The Case of Alzheimer’s Disease
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_5 · Cited by 22 · see citing works
Food for Thought: Leptin and Hippocampal Synaptic Function
Harvey, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.882158 · Cited by 22 · see citing works
Hayes, J. P., Moody, J. N., Roca, J. G., & Hayes, S. M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102156 · Cited by 21 · see citing works
Popelová, A., Pražienková, V., Neprašová, B., Kasperová, B. J., Hrubá, L., Holubová, M., Zemenová, J., Blum, D. L., Železná, B., Galas, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171041 · Cited by 21 · see citing works
- Authors
- Hassing, L. B., Dahl, A. K., Thorvaldsson, V, Berg, S., Gatz, M., Pedersen, N. L., & Johansson, B.
- Affiliations
- University of Gothenburg (SE)
- Jönköping University (SE)
- University of Southern California (US)
- Corresponding author
- Hassing, L B
- Venue
- International Journal of Obesity
- Published
- 2009-06-09
- Volume
- 33
- Issue
- 8
- Pages
- 893-898
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- PMC
- PMC3025291
- OpenAlex
- W1971559855
- Semantic Scholar
- 148f24651fd855dd68fba99dc9a43aa9bd9b3532
- Cited by
- 197
- References
- 36
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 8 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 20 · 2019: 13 · 2018: 13 · 2017: 8 · 2016: 11 · 2015: 13 · 2014: 17 · 2013: 13 · 2012: 6
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG004563, AG-10175, R37AG008861, AG04563, AG 08724, AG 08861, R01AG010175, R01AG008724)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- overweight, midlife, dementia risk, Alzheimer's disease, vascular dementia, body mass index, diabetes mellitus, vascular disease, APOE ε4, sex differences, Swedish Twin Registry
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Sweden, Dementia, Vascular, Body Mass Index, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review